No impact of donor type on allogeneic transplantation (ALLOHCT) outcomes in patients with myeloid malignity >= 60 years old

Jindra, P; Cepek, P; Houdova, L; Karas, M; Holubova, M; Lysak, D; Schneiderova, V

HLA, 2022; 99 (5): 499